Related Experiment Video

Updated: Aug 10, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy

Hyung-Joon Kwon1,2, Nayoung Kim3,4, Hun Sik Kim1,2

  • 1Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Experimental & Molecular Medicine
|April 1, 2017
PubMed

Insights

Natural killer (NK) cells show promise in cancer therapy by selectively targeting tumors. Understanding and targeting NK cell activation checkpoints can enhance their anti-cancer activity for improved therapeutic strategies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
  • NK cell effector functions, including cytokine production and direct cytotoxicity, are vital for anti-cancer activity.
  • NK cell activation requires co-engagement of multiple activating receptors due to intrinsic inhibitory mechanisms.

Purpose of the Study:

  • To explore the molecular checkpoints that regulate natural killer (NK) cell activation.
  • To identify therapeutic targets for enhancing NK cell-mediated cancer therapy.
  • To understand how to overcome NK cell inhibition for broader anti-cancer applications.

Main Methods:

  • Analysis of natural killer (NK) cell receptor-ligand interactions.
  • Investigation of signaling pathways governing NK cell activation and inhibition.
  • Identification of molecular checkpoints controlling NK cell responses.

Main Results:

  • NK cell activation is regulated by a complex interplay of multiple activating receptors and inhibitory checkpoints.
  • Redundant activating receptors and single inhibitory receptor classes suggest common control mechanisms.
  • Specific molecular checkpoints have been identified as key regulators of NK cell function.

Conclusions:

  • Targeting molecular checkpoints can lower NK cell activation thresholds.
  • Harnessing NK cell checkpoints offers a promising strategy to enhance anti-cancer immunotherapy.
  • Optimizing NK cell reactivity through checkpoint modulation can improve therapeutic outcomes in diverse cancers.

More Related Videos

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.